布莱顿协作标准化模板,主要考虑基于非复制修饰的疫苗病毒安卡拉病毒载体的病毒载体疫苗的益处风险评估
Ellen K Link1, Alina Tscherne1, Gerd Sutter1
1Ludwig-Maximilians-University Munich (LMU Munich), Department of Veterinary Sciences, Division of Virology, Oberschleißheim, Germany.
Vaccine
|November 29, 2024
概括
修改的疫苗病毒安卡拉 (MVA) 载体疫苗,如MVA-MERS-S,显示出对抗新兴传染病的希望. 这种MVA平台在临床前和临床研究中是安全的,免疫的和有效的.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- 新兴的动物性传染病,如中东呼吸系统综合征冠状病毒 (MERS-CoV),对全球公共卫生构成重大挑战.
- 安全有效的疫苗对于控制传染病爆发至关重要.
- 布莱顿协作技术对疫苗的利益风险评估 (BRAVATO) 倡议侧重于评估新型疫苗技术.
研究的目的:
- 提供修改后疫苗病毒安卡拉 (MVA) 载体疫苗的概述.
- 审查MVA平台的分子和生物特征.
- 关于针对MERS-CoV.的MVA-MERS-S候选疫苗的数据.
主要方法:
- 审查MVA载体技术及其在疫苗开发中的应用.
- 在临床前动物模型中评估MVA-MERS-S.
- 对临床试验数据的分析,包括一项Ib期研究,涉及超过170名参与者.
主要成果:
- 在临床前模型和人类中,MVA-MERS-S耐受性良好,并且具有免疫性.
- 候选疫苗诱导了细胞和幽默免疫反应.
- 该MVA平台证明了安全性,免疫性和有效性.
结论:
- MVA 载体平台是针对新出现的传染病开发疫苗的可行和有效工具.
- MVA-MERS-S代表了对MERS-CoV.的有希望的疫苗候选人.
- 该MVA平台支持安全,免疫性和高效的疫苗的创建.
相关概念视频
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...


